Skip to main content
. 2016 Jan;356(1):116–122. doi: 10.1124/jpet.115.228882

Fig. 2.

Fig. 2.

Effect of the irreversible A1 adenosine receptor antagonist FSCPX (10 µM, 60 minutes) on CPA-mediated inhibition of EFS-elicited human detrusor contractions. As shown, FSCPX blocks the inhibition of EFS human detrusor muscle contractions by CPA (CPA, n = 5; FSCPX + CPA, n = 7).